Biodesix (BDSX) Total Non-Current Liabilities: 2019-2025
Historic Total Non-Current Liabilities for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $72.3 million.
- Biodesix's Total Non-Current Liabilities rose 16.74% to $72.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.3 million, marking a year-over-year increase of 16.74%. This contributed to the annual value of $62.1 million for FY2024, which is 1.56% up from last year.
- According to the latest figures from Q3 2025, Biodesix's Total Non-Current Liabilities is $72.3 million, which was up 1.19% from $71.4 million recorded in Q2 2025.
- In the past 5 years, Biodesix's Total Non-Current Liabilities ranged from a high of $72.3 million in Q3 2025 and a low of $24.1 million during Q1 2022.
- In the last 3 years, Biodesix's Total Non-Current Liabilities had a median value of $61.9 million in 2025 and averaged $61.9 million.
- Per our database at Business Quant, Biodesix's Total Non-Current Liabilities slumped by 61.77% in 2022 and then surged by 125.05% in 2023.
- Biodesix's Total Non-Current Liabilities (Quarterly) stood at $27.4 million in 2021, then skyrocketed by 80.45% to $49.5 million in 2022, then increased by 23.53% to $61.1 million in 2023, then increased by 1.56% to $62.1 million in 2024, then rose by 16.74% to $72.3 million in 2025.
- Its Total Non-Current Liabilities stands at $72.3 million for Q3 2025, versus $71.4 million for Q2 2025 and $61.9 million for Q1 2025.